Press release
Leading Element Driving Change in the Self-Administered Parenteral Market in 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion Driver
Self Administered Parenteral Market
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the self-administered parenteral market. Chronic diseases are enduring health conditions that typically develop gradually and frequently necessitate continuous care and treatment. Self-administered parenteral products play a pivotal role in managing chronic conditions, allowing individuals to control their treatments, which can result in increased adherence over oral medications. To illustrate, the National Institutes of Health, a US government agency, projected that by January 2023, there would be a 99.5% increase in individuals aged 50 and above suffering from at least one chronic disease, from 71.522 million in 2020 to 142.66 million by 2050. Consequently, this rise in chronic disease prevalence is propelling the growth of the self-administered parenteral market.
Get Your Self-Administered Parenteral Market Report Here:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report
What is the projected compound annual growth rate (CAGR) of the self-administered parenteral market from 2025 to 2034, and what factors influence it?
In recent times, the self-administered parenteral market has seen robust growth. Projected to increase from $24.57 billion in 2024 to $26.04 billion in 2025, it has a compound annual growth rate (CAGR) of 6.0%. This growth in the previous period was primarily driven by the increase in chronic diseases, an aging global population, government policy changes, patient educational initiatives, support programs, and a spike in bone disorder cases.
The market size of self-administered parenteral treatments is predicted to experience consistent expansion in the coming years, reaching a value of $31.18 billion in 2029 with a 4.6% compound annual growth rate (CAGR). The expected growth during the forecast period is due to factors such as a rising preference for home healthcare among patients, advancements in telemedicine and remote patient monitoring, enhanced patient education and support measures, along with the increase in personalized medicine. Key trends expected to shape the market during the forecast period include the incorporation of digital health solutions, tailored drug delivery systems, the development of targeted therapies, and advancements in biologics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp
How are the latest trends influencing the growth of the self-administered parenteral market?
Leading firms in the self-administered parenteral industry are concentrating on the creation of groundbreaking products such as the UDENYCA autoinjector, with the aim to extend options and control to patients, thereby enhancing the accessibility of treatments. An autoinjector is a medical apparatus specifically engineered to administer a single dosage of a specific drug, with its design geared towards easy usage, and the drug administration set off reliably and instantly by skin contact. For example, Coherus BioSciences Inc., a biotech firm based in the US, unveiled the UDENYCA autoinjector in May 2023. This self-administered parenteral medication available in the US is a solitary-dose, pre-filled autoinjector that provides patients with an alternative route for administering pegfilgrastim. Its design is user-friendly and intuitive, with skin contact triggering drug delivery, guaranteeing a full pegfilgrastim dose is dispensed instantly and reliably. Moreover, it provides several features that facilitate successful delivery such as quick dosage, intuitive design, dual coverage and options for both home and office use, in addition to reducing the risk of febrile neutropenia.
What are the major segments of the self-administered parenteral market and their role in driving growth?
The self-administered parenteral market covered in this report is segmented -
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the self-administered parenteral market?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp
What Is Covered In The Self-Administered Parenteral Global Market Report?
•Market Size Forecast: Examine the self-administered parenteral market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the self-administered parenteral market for a structured understanding.
•Key Players Overview: Analyze major players in the self-administered parenteral market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the self-administered parenteral market.
•Segment Contributions: Evaluate how different segments drive overall growth in the self-administered parenteral market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the self-administered parenteral market.
•Industry Challenges: Identify potential risks and obstacles affecting the self-administered parenteral market.
•Competitive Landscape: Review strategic developments in the self-administered parenteral market, including expansions, agreements, and new product launches.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Self-Administered Parenteral Market in 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion Driver here
News-ID: 3920695 • Views: …
More Releases from The Business Research Company
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Lo …
The long-chain polyamide market is poised for notable expansion in the coming years, driven by evolving demands and technological advancements. This report delves into market size projections, key players, emerging trends, and segment analysis, providing a comprehensive overview of the sector's outlook through 2030.
Anticipated Market Size and Growth Trajectory for Long-Chain Polyamide
The valuation of the long-chain polyamide market is projected to reach $3.42 billion by 2030, growing at…
Key Players and Competitive Dynamics in the Intravenous (IV) Compounding Robots …
The intravenous (IV) compounding robots market is poised for significant expansion in the coming years as healthcare facilities increasingly seek advanced solutions to improve drug preparation safety and efficiency. With advancements in technology and growing healthcare demands, this market is set to transform pharmacy operations and enhance patient care.
Intravenous IV Compounding Robots Market Size and Growth Projections
The market for intravenous compounding robots is anticipated to reach $0.99 billion…
Segmentation Analysis, Market Trends, and Competitive Landscape in the Inorganic …
The inorganic ceramic membrane market is positioned for remarkable growth over the coming years, driven by technological advances and increasing applications across various industries. This market's expansion reflects a growing need for efficient and sustainable filtration solutions, especially in sectors like water treatment and pharmaceuticals. Let's explore the market's projected growth, key players, emerging trends, and major segments to understand the evolving landscape of inorganic ceramic membranes.
Projected Market Size and…
Leading Companies Propelling Innovation and Growth in the Human Behavior Tool Ma …
Understanding the potential of the human behavior tool market reveals significant opportunities driven by rapid technological advances and increasing demand for data-driven insights. As organizations seek to better understand and predict human actions, this market is positioned to experience notable expansion in the coming years. Let's explore the market's growth forecasts, key players, emerging trends, and segmentations shaping its future.
Projected Expansion in the Human Behavior Tool Market by 2030 …
More Releases for Administered
Self-Administered Drugs Market Global Rising Demand & Huge Scope Till 2032
The global self-administered drugs market was valued at approximately USD 95.53 billion in 2023 and is projected to reach USD 204.08 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2032.
Self-Administered Drugs Market Overview
The self-administered drugs market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases such as diabetes, asthma, and osteoporosis. Patients are seeking convenient and effective…
Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fu …
How Will the Self-Administered Parenteral Market Grow, and What Is the Projected Market Size?
The self-administered parenteral market has experienced strong growth in recent years. It will rise from $24.57 billion in 2024 to $26.04 billion in 2025, at a CAGR of 6.0%. This growth is driven by the rise in chronic diseases, the aging population, government initiatives, patient education and support programs, and the increasing incidences of bone disorders.
The self-administered…
Self-administered Drugs Market 2023 Trends with Analysis on Key Players
Drugs that are administered by patients themselves are known as self-administered drugs. These drugs can be taken through implantable and non-implantable infusion pumps that come in contact with the skin surface. OTC, Oral and Topical preparations are also considered self-administered drugs. Active lifestyles have prompted patients to seek drugs that would not only save time, but would enable them to avoid hospitals altogether (except in emergency cases).
Self-administered Drugs Market research…
Self-Administered Medication Market to Register Substantial Expansion by 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Request for a sample of this research report @ https://www.xploremr.com/connectus/sample/1929
Scope
The…
Self-Administered Medication Market Progresses for Huge Profits During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1929
Scope
The scope of…
Self-Administered Medication Market to Register Unwavering Growth During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
Report overview @ https://www.xploremr.com/report/1929/self-administered-medication-market
This Fact.MR report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Scope
The scope of Fact.MR’s report is to analyze…
